Collaborating Across Sectors to Further Global Health
The Sustainable Development Goals (SDGs) are 17 specific goals, and 169 associated targets that set out quantitative objectives across the social, economic, and environmental dimensions of sustainable development, all to be achieved by 2030 (United Nations, 2015). Health has been recognized as crucial for sustainable human development (Alleyne et al., 2013) and an essential contributor […]
Tackling Antimicrobial Resistance in Food and Agricultural Sectors
With the release in May of the final report and recommendations of the Review on Antimicrobial Resistance, GBCHealth has convened a group of global leaders to discuss the potential impact of AMR and their priorities for immediate action. The #GBCtalksAMR series, which will be published over the next three weeks is intended to supplement the […]
GBCHealth Talks Antimicrobial Resistance with GE Foundation
Interview with Dr. David M. Barash, Executive Director, Global Health Portfolio & Chief Medical Officer, GE Foundation With the release in May of the final report and recommendations of the Review on Antimicrobial Resistance, GBCHealth has convened a group of global leaders to discuss the potential impact of AMR and their priorities for immediate action. […]
The Impact of AMR and Priorities for Immediate Action
Interview with Dr. Nafsiah Mboi, Special Envoy for the Asia-Pacific Leaders Malaria Alliance With the release in May of the final report and recommendations of the Review on Antimicrobial Resistance, GBCHealth has convened a group of global leaders to discuss the potential impact of AMR and their priorities for immediate action. The series, which will […]
A Global Discussion on Antimicrobial Resistance
With the release in May of the final report and recommendations of the Review on Antimicrobial Resistance, GBCHealth has convened a group of global leaders to discuss the potential impact of AMR and their priorities for immediate action. The interview series, which will be published over the next three weeks, is intended to supplement the […]
Personal Perspectives on the Corporate Response to HIV/AIDS
Interview with Michel Sidibé, Executive Director, Joint United Nations Programme on HIV/AIDS (UNAIDS) This interview is the second in a four-part series in which experts reflect on the progress made since the groundbreaking AIDS 2000 Conference in Durban and the challenges that remain. The 21st International AIDS Conference is being held in Durban, South Africa, […]
Big Opportunities and Inspiring Examples on World Hepatitis Day
A few years ago I had the privilege of leading a team of highly committed health professionals to provide healthcare services to some of the most marginalised people in our world: rural communities in South Sudan who were enduring immeasurable suffering from the 22 year civil war and ongoing ethnic conflicts. We trained nurses, midwives […]
Refelctions on the Corporate Response to HIV/AIDS
This interview with Kelly Curran, Director of HIV/AIDS and Infectious Diseases at Jhpiego, is the first in a four-part series in which experts reflect on the progress made since the groundbreaking AIDS 2000 Conference in Durban and the challenges that remain. The 21st International AIDS Conference is being held in Durban, South Africa, July 18-22. […]
An Introduction to GBCHealth’s HIV/AIDS Expert Interview Series
Bolstered by the global multisector response to Ebola and Zika over the past two years, I have found myself reflecting on the origins of business engagement in the HIV/AIDS pandemic when MTV Networks and the Financial Times came together with four large pharmaceutical companies to start the Global Business Council, which eventually became GBCHealth. Since […]
Reflections from the Private Sector at AIDS 2016
The 21st International AIDS Conference, also known as AIDS 2016, was expected to have nearly 20,000 people from around the globe gathering in Durban, South Africa to show their support for the fight against AIDS. This year’s theme, “Access Equity Rights Now,” issued a clear call-to-action to address the inequality in care, treatment and prevention. […]
Caring for Underserved Children Affected by Life-threatening Rare Diseases
While working at Merck Serono in the R&D knowledge management department, Caroline Kant discovered many drugs sitting on the company’s shelves, waiting to be researched on and which could become part of a much needed solution to treat rare diseases. As a mother of a child affected by an unidentified rare disease herself, Caroline decided […]
Supporting Research in Neglected Tropical Diseases
Neglected Tropical Diseases (NTDs) seriously undermine the physical and cognitive health and economic opportunity of more than one billion people, most of them among the world’s poorest populations and least able to access or advocate for solutions. Although encouraging progress has been made in recent decades, the prevention, control, elimination and eradication of these diseases […]
Saving the Lives of One Million Children
GSK’s partnership with Save the Children is a Finalist in the Unilever Global Development Award supported by Business Fights Poverty. We asked them some questions about their programme and the global development impacts achieved. Q) What challenge does the GSK-Save the Children partnership serve to change? In 2015, 5.9 children under the age of five […]
Bringing Sustainable Energy to Informal Settlements
Pollinate Energy is a Finalist in the Unilever Global Development Award supported by Business Fights Poverty. We asked them some questions about their programme and the lessons learnt. Q) What challenge does Pollinate Energy’s programme serve to change? 400 million people live in India without electricity. Wood cooking fires and kerosene lamps cause epidemic levels […]
Increasing Supply and Demand for Healthcare in Kenya
In a country where one child in 19 dies before their fifth birthday, a typical scenario in Kenya’s western county of Bungoma can be; a mother-to-be is feeling ill; she is not sure whether she should go to hospital, but the husband doesn’t think it’s important, so she stays home. Or the husband is supportive, […]
Innovations in Safe Water for Millions
Unsafe drinking water is a global problem that affects more than 660 million people every day. And yes, we know there are low-cost solutions that have been proven to work in rigorous scientific studies – for millions of people with the least access to safe drinking water. Evidence Action is a social enterprise that develops […]
To Help Save Children’s Lives, We Need to Be Bold
Only by breaking down boundaries and working together in unprecedented ways can we tackle the entrenched issues which cause millions of children to continue to die each year from preventable causes. That was the shared understanding which brought GSK and Save the Children together three years ago, creating a groundbreaking partnership to help save one […]
Delivering Dignity through Healthcare
Geel Medical Services is a Finalist in the Unilever Global Development Award supported by Business Fights Poverty. We asked them some questions about their programme and the global development impacts achieved. Q) What challenge does GEEL Medical Services (GMS) serve to change? A) The doctor-patient ratio in rural communities in sub Saharan Africa is much […]
Preparing to Stop Drug-resistant Malaria
By David Reddy, CEO, Medicines for Malaria Venture and Jürgen Brokatzky-Geiger, Global Head of Corporate Responsibility, Novartis. No child should ever die from a mosquito bite. Yet, today, in an era of extraordinary medical advancement, a child dies of mosquito-borne malaria every two minutes. Last year, this agonizing blood disease caused by the malaria parasite […]
Pointing the Way for Cross-sector Collaborations
One of the most striking aspects of the current healthcare landscape is the way that the whole world is now so interconnected and so interdependent. This is changing the way we see health, creating a new global perspective that will affect the way we need to act. Against this backdrop, we need to understand better […]